DaehanPharmaceutical

KOSDAQ:023910

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is DaehanPharmaceutical's stock price target?

Price Target

40 800 KRW

According to Wall Street analysts, the average 1-year price target for DaehanPharmaceutical is 40 800 KRW with a low forecast of 40 400 KRW and a high forecast of 42 000 KRW.

What is the Revenue forecast for DaehanPharmaceutical?

Projected CAGR

4%

Over the last 13 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 3 years is 4%.

What is the Gross Profit forecast for DaehanPharmaceutical?

Projected CAGR

6%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 2 years is 6%.

What is the Operating Income forecast for DaehanPharmaceutical?

Projected CAGR

9%

Over the last 13 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 9%.

What is the Pre-Tax Income forecast for DaehanPharmaceutical?

Projected CAGR

8%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 2 years is 8%.

What is the Net Income forecast for DaehanPharmaceutical?

Projected CAGR

12%

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 2 years is 12%.